MARY DWYER: Open Payments
NPI 1255808747 · GREENVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 49 payments from 11 companies in 2025. Trend: 2023 $1,190 · 2024 $862 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $388 |
| ABBVIE INC. | 4 | $86 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Corium, LLC | 2 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
Products named: CAPLYTA, FANAPT, UBRELVY, VRAYLAR, Kerendia, VOQUEZNA, Azstarys, MOUNJARO.
Industry payments across KY — which companies pay providers there.
